Researchers are also exploring the use of these drugs in a wide range of diseases, including chronic kidney disorders, fatty liver disease, neurodegenerative conditions like Alzheimers and Parkinsons, and addictions
Regarding GLP-1 therapies, the SURMOUNT-1 trial demonstrated tirzepatide's superior efficacy, with participants achieving up to 22.5% total body weight reduction at the 15mg dose
What I definitely dont recommend is getting sidetracked by those patches or other alternatives that arent actually proven to work
Once acquired, then I became medical director for all of WeightWatchers. Remi Cossart and Calvin Young both were excited about the potential for GLP-1s to revolutionize how we approach weight health
Biochem Biophys Res Commun 317: 55864
BPC-157 therapy may also be considered by individuals participating in wellness or longevity-focused programs who want additional support for recovery, circulation, or general physical resilience